Anteris Technologies Global Corp. Common Stock (AVR)

• Market cap: $179M
• 1 day: -3.11%
• 5 days: 72.92%
• 1 month: 1.22%
• 3 months: -17.00%
• 6 months: -11.07%
• Year to date: -10.27%
• 1 year: -11.07%
• 5 years: -11.07%
• 10 years: -11.07%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

45.27% more ownership

Funds ownership: 0% [Q3] → 45.27% (+45.27%) [Q4]